Literature DB >> 2065501

Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause.

G La Montagna1, M Vatti, G Valentini, G Tirri.   

Abstract

Ninety systemic sclerosis (SSc) patients, all females, none of them suffering from either renal failure or intestinal malabsorption, and 90 sex and age matched controls were investigated for bone mineral content (BMC) by dual photon-absorptiometry (Am 241, I 125) (Osteoden P, NIM) evaluated at two sites of the nondominant radius. BMC as well as bone density (BD) were found to be significantly lower in the patients than in the controls. No alteration of calcium metabolism was detected in the patients, neither were we able to find any relationship between osteopenia and the extent of the involvement of the skin or of any internal organ. We observed, however, that the percentage of the patients in menopause was significantly greater than that of the controls (p less than .001). Furthermore, menopause had occurred in the patients significantly earlier than in the controls (p less than .001). Therefore, earlier menopause can play a role in the induction of osteopenia in systemic sclerosis. Further prospective studies are needed to check the hormonal status of SSc patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065501     DOI: 10.1007/BF02208027

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

1.  Bone mineral content in systemic sclerosis measured by photonabsorptiometry.

Authors:  J Serup; H Hagdrup; E Tvedegaard
Journal:  Acta Derm Venereol       Date:  1983       Impact factor: 4.437

2.  The arthropathy of advanced progressive systemic sclerosis. A radiographic survey.

Authors:  K L Blocka; L W Bassett; D E Furst; P J Clements; H E Paulus
Journal:  Arthritis Rheum       Date:  1981-07

3.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

4.  A model for involutional bone loss.

Authors:  J F Aloia; A Vaswani; K Ellis; K Yuen; S H Cohn
Journal:  J Lab Clin Med       Date:  1985-12

5.  Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.

Authors:  M Giordano; G Valentini; S Migliaresi; U Picillo; M Vatti
Journal:  J Rheumatol       Date:  1986-10       Impact factor: 4.666

6.  Mineral metabolism in postmenopausal women with active rheumatoid arthritis.

Authors:  A Verstraeten; J Dequeker
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

  6 in total
  14 in total

1.  Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency.

Authors:  Samuel Katsuyuki Shinjo; Eloisa Bonfá; Valéria de Falco Caparbo; Rosa Maria Rodrigues Pereira
Journal:  Rheumatol Int       Date:  2010-03-25       Impact factor: 2.631

2.  Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Fahd Wafki; Fatima Znat; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

3.  Uterine prolapse in a young nulligravida with scleroderma and premature ovarian failure.

Authors:  Birol Vural; Eray Caliskan; Emek Doger; Cengiz Ercin
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-01-15

4.  Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis.

Authors:  M M Sampaio-Barros; J C Alvarenga; L Takayama; A P L Assad; P D Sampaio-Barros; R M R Pereira
Journal:  Osteoporos Int       Date:  2019-04-27       Impact factor: 4.507

5.  Risk factors for body composition abnormalities in systemic sclerosis.

Authors:  Thais F Marighela; Patrícia de S Genaro; Marcelo M Pinheiro; Vera L Szejnfeld; Cristiane Kayser
Journal:  Clin Rheumatol       Date:  2013-04-03       Impact factor: 2.980

Review 6.  Menopause and Rheumatic Disease.

Authors:  Mitali Talsania; Robert Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2017-05       Impact factor: 2.670

7.  Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis.

Authors:  O Di Munno; M Mazzantini; P Massei; M Ferdeghini; N Pitaro; A Latorraca; C Ferri
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

8.  Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.

Authors:  Addolorata Corrado; Ripalta Colia; Angiola Mele; Valeria Di Bello; Antonello Trotta; Anna Neve; Francesco Paolo Cantatore
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 9.  The role of IL-1β in the bone loss during rheumatic diseases.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Carubbi; Vasiliki Liakouli; Francesca Zazzeroni; Paola Di Benedetto; Onorina Berardicurti; Edoardo Alesse; Roberto Giacomelli
Journal:  Mediators Inflamm       Date:  2015-04-12       Impact factor: 4.711

10.  Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study.

Authors:  Marco Atteritano; Stefania Sorbara; Gianluca Bagnato; Giovanni Miceli; Donatella Sangari; Salvatore Morgante; Elisa Visalli; Gianfilippo Bagnato
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.